Year: 2022

news_6

InnoCare Announces First Patient Dosed in Phase II Registrational Trial of Tafasitamab in Combination with Lenalidomide for Relapsed or Refractory Diffuse Large B-Cell Lymphoma in China

BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969) announced today that the first patient was dosed in the phase II registrational trial (Registry...

logo-36

Asia Pacific Air Cargo Market Report 2022: A $59.29 Billion Market by 2028 – Rational Cool Chain Solutions Gaining Momentum & Expanding Airport Infrastructure in Southeast Asia and New Policies – ResearchAndMarkets.com

logo-35

World Bottled Water Market Report 2022: A $322.85 Billion Market by 2028 – Growing Acceptance of Premium Bottled Water & Shift in Demand from Carbonated Soft Drinks to Bottled Water – ResearchAndMarkets.com